LifeMD Announces Board and Executive Compensation Changes
Ticker: LFMDP · Form: 8-K · Filed: Dec 23, 2024 · CIK: 948320
Sentiment: neutral
Topics: board-changes, executive-compensation
Related Tickers: LFMD
TL;DR
LifeMD swapped a director and tweaked exec pay on 12/18.
AI Summary
LifeMD, Inc. announced on December 18, 2024, a change in its board of directors and executive compensation arrangements. Specifically, the company reported the departure of a director and the election of a new director, alongside updates to the compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence.
Risk Assessment
Risk Level: medium — Changes in board and executive compensation can indicate internal shifts that may affect future performance or governance.
Key Players & Entities
- LifeMD, Inc. (company) — Registrant
- December 18, 2024 (date) — Date of earliest event reported
FAQ
Who departed from the LifeMD board of directors?
The filing indicates a departure of a director, but the specific name is not provided in this summary.
Who was elected to the LifeMD board of directors?
The filing indicates the election of a new director, but the specific name is not provided in this summary.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is December 18, 2024.
What specific items are being reported in this 8-K filing?
This 8-K filing reports on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What was LifeMD, Inc.'s former name?
LifeMD, Inc. was formerly known as Conversion Labs, Inc. and Immudyne, Inc. (also Immudyne Inc).
Filing Stats: 447 words · 2 min read · ~1 pages · Grade level 11.3 · Accepted 2024-12-23 16:05:39
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share LFMD The Nasdaq Capital M
- $0.0001 — A Cumulative Perpetual Preferred Stock, $0.0001 per share LFMDP The Nasdaq Capital
Filing Documents
- form8-k.htm (8-K) — 38KB
- 0001493152-24-051819.txt ( ) — 256KB
- lfmd-20241218.xsd (EX-101.SCH) — 4KB
- lfmd-20241218_def.xml (EX-101.DEF) — 29KB
- lfmd-20241218_lab.xml (EX-101.LAB) — 36KB
- lfmd-20241218_pre.xml (EX-101.PRE) — 26KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LIFEMD, INC. Dated: December 23 , 2024 By: /s/ Eric H. Yecies Eric H. Yecies Chief Legal Officer and General Counsel